4.8 Article

The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens

Journal

MOLECULAR PSYCHIATRY
Volume 20, Issue 11, Pages 1448-1459

Publisher

SPRINGERNATURE
DOI: 10.1038/mp.2015.104

Keywords

-

Funding

  1. ANR [ANR-09-MNPS-033, ANR-13-SAMA-0005-01]
  2. Equipe FRM [DEQ20130326486]
  3. FRC
  4. Brain Canada Multi-Investigator Research Initiative
  5. Djavad Mowafaghian Foundation
  6. ERANET-Neuron Joint Transnational Call for 'European Research Projects on Mental Disorders'
  7. INSERM
  8. CNRS
  9. UPMC
  10. French state funds [ANR-11-IDEX-0004-02]
  11. Ecole des Neurosciences de Paris
  12. City of Paris
  13. Inserm Atip-Avenir
  14. Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT)
  15. Departement de la Recherche Clinique et du Developpement-Assistance Publique Hopitaux de Paris (DRCD-APHP) [OST07013]
  16. Programme Hospitalier de Recherches Cliniques (PHRC program) [AOM10165]
  17. Agence Nationale de la Recherche (ANR) [ANR-13-SAMA-0005] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

Tonically active cholinergic interneurons (TANs) from the nucleus accumbens (NAc) are centrally involved in reward behavior. TANs express a vesicular glutamate transporter referred to as VGLUT3 and thus use both acetylcholine and glutamate as neurotransmitters. The respective roles of each transmitter in the regulation of reward and addiction are still unknown. In this study, we showed that disruption of the gene that encodes VGLUT3 (Slc17a8) markedly increased cocaine self-administration in mice. Concomitantly, the amount of dopamine (DA) release was strongly augmented in the NAc of VGLUT3(-/-) mice because of a lack of signaling by metabotropic glutamate receptors. Furthermore, dendritic spines and glutamatergic synaptic transmission on medium spiny neurons were increased in the NAc of VGLUT3(-/-) mice. Increased DA and glutamate signaling in the NAc are hallmarks of addiction. Our study shows that TANs use glutamate to reduce DA release and decrease reinforcing properties of cocaine in mice. Interestingly, we also observed an increased frequency of rare variations in SLC17A8 in a cohort of severe drug abusers compared with controls. Our findings identify VGLUT3 as an unexpected regulator of drug abuse.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders

Beltran Alvarez-Perez, Herve Poras, Rafael Maldonado

Summary: Dual enkephalinase inhibitors (DENKIs) provide an innovative strategy to activate opioid receptors and treat opioid use disorders by protecting endogenous opioid peptides. They have the potential to be a safe and effective treatment for acute opioid withdrawal and a promising alternative to opioid substitution therapy with minimized side effects.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Psychology, Clinical

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study

Victoria Rodriguez, Luis Alameda, Diego Quattrone, Giada Tripoli, Charlotte Gayer-Anderson, Edoardo Spinazzola, Giulia Trotta, Hannah E. Jongsma, Simona Stilo, Caterina La Cascia, Laura Ferraro, Daniele La Barbera, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, Elena Bonora, Stephane Jamain, Jean-Paul Selten, Eva Velthorst, Lieuwe de Haan, Pierre-Michel Llorca, Manuel Arrojo, Julio Bobes, Miguel Bernardo, Celso Arango, James Kirkbride, Peter B. Jones, Bart P. Rutten, Alexander Richards, Pak C. Sham, Michael O'Donovan, Jim Van Os, Craig Morgan, Marta Di Forti, Robin M. Murray, Evangelos Vassos

Summary: This study suggests that combining polygenic risk scores (PRS) for severe psychiatric disorders with prediction models for psychosis phenotypes can improve discrimination ability and enhance our understanding of these phenotypes. PRS may have potential usefulness in specific populations such as those at high risk or in the early stages of psychosis.

PSYCHOLOGICAL MEDICINE (2023)

Article Neurosciences

Silencing KCC2 in mouse dorsal hippocampus compromises spatial and contextual memory

Clemence Simonnet, Manisha Sinha, Marie Goutierre, Imane Moutkine, Stephanie Daumas, Jean Christophe Poncer

Summary: The downregulation of KCC2 is associated with altered hippocampal rhythmogenesis and neuronal hyperexcitability, leading to deficits in spatial and contextual memory. Reduced KCC2 expression and function may disrupt GABA signaling and contribute to neurological and psychiatric disorders.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Neurosciences

Disruption of Astrocyte-Dependent Dopamine Control in the Developing Medial Prefrontal Cortex Leads to Excessive Grooming in Mice

Francesco Petrelli, Tamara Zehnder, Anthony Laugeray, Sarah Mondoloni, Corrado Cali, Luca Pucci, Alicia Molinero Perez, Bianca Maria Bondiolotti, Eva De Oliveira Figueiredo, Glenn Dallerac, Nicole Deglon, Bruno Giros, Lorenzo Magrassi, Jean-Pierre Mothet, Manuel Mameli, Linda D. Simmler, Paola Bezzi

Summary: This study investigates the relationship between VMAT2 in astrocytes and the regulation of DA levels, finding that impairment of astrocytic control of DA leads to reduced DA levels, excessive grooming, and compulsive repetitive behaviors. The expression of VMAT2 in human PFC astrocytes validates the translational relevance of these findings.

BIOLOGICAL PSYCHIATRY (2023)

Article Clinical Neurology

Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression

Chiara C. Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Trang T. T. Truong, Timothy Connor, Courtney Swinton, Bruna Panizzutti, Zoe S. J. Liu, Andrew Sanigorski, Olivia M. Dean, Tamsyn Crowley, Mark Richardson, Kiymet Bozaoglu, Katerina Vlahos, Stephanie Cowdery, Brad Watmuff, Stephan F. Steyn, De Wet Wolmarans, Barend J. Engelbrecht, Christina Perry, Katherine Drummond, Terence Pang, Stephane Jamain, Laura Gray, Sean L. McGee, Brian H. Harvey, Jee Hyun Kim, Marion Leboyer, Michael Berk, Ken Walder

Summary: The aim of this study was to identify a drug for repurposing in the treatment of bipolar depression. A gene expression signature was generated using human neuronal-like cells to represent the effects of drugs used to treat bipolar disorder. Trimetazidine was identified as a potential candidate for repurposing based on its similar transcriptional effects and its ability to increase ATP production.

BIPOLAR DISORDERS (2023)

Article Biochemistry & Molecular Biology

Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

Margaret Haney, Monique Vallee, Sandy Fabre, Stephanie Collins Reed, Marion Zanese, Ghislaine Campistron, Caroline A. Arout, Richard W. Foltin, Ziva D. Cooper, Tonisha Kearney-Ramos, Mathilde Metna, Zuzana Justinova, Charles Schindler, Etienne Hebert-Chatelain, Luigi Bellocchio, Adeline Cathala, Andrea Bari, Roman Serrat, David B. Finlay, Filippo Caraci, Bastien Redon, Elena Martin-Garcia, Arnau Busquets-Garcia, Isabelle Matias, Frances R. Levin, Francois-Xavier Felpin, Nicolas Simon, Daniela Cota, Umberto Spampinato, Rafael Maldonado, Yavin Shaham, Michelle Glass, Lars Lykke Thomsen, Helle Mengel, Giovanni Marsicano, Stephanie Monlezun, Jean-Michel Revest, Pier Vincenzo Piazza

Summary: Cannabis use disorder (CUD) is a widespread problem with no current pharmacological treatment options. AEF0117, a signaling-specific inhibitor of the cannabinoid receptor 1, has shown promise in reducing self-administration of cannabis and THC-related behavioral impairment without significant adverse effects in animal studies. Clinical trials involving healthy volunteers and individuals with CUD found that AEF0117 was safe, well tolerated, and significantly reduced the positive subjective effects of cannabis.

NATURE MEDICINE (2023)

Article Neurosciences

Role of CB2 cannabinoid receptor in the development of food addiction in male mice

A. Garcia-Blanco, A. Ramirez-Lopez, F. Navarrete, M. S. Garcia-Gutierrez, J. Manzanares, E. Martin-Garcia, R. Maldonado

Summary: The endocannabinoid system plays a crucial role in behavioral responses in the central nervous system. The cannabinoid CB1 receptor is associated with loss of behavioral control during food addiction, while the CB2 receptor is linked to addictive-like behavior and drug addiction. In this study, the specific role of CB2R in food addiction was evaluated using an operant mouse model. It was found that the lack of CB2R provides protection against the development of food addiction and associated impulsive and depressive-like behavior, while overexpression of CB2R increases vulnerability to food addiction. Transcriptomic changes were also observed, providing mechanistic explanations for these behavioral changes. Therefore, CB2R may serve as a potential therapeutic target for regulating eating control and managing emotional effects in food addiction.

NEUROBIOLOGY OF DISEASE (2023)

Article Psychology, Clinical

Definition of early age at onset in bipolar disorder according to distinctive neurodevelopmental pathways: insights from the FACE-BD study

Filippo Corponi, Antoine Lefrere, Marion Leboyer, Frank Bellivier, Ophelia Godin, Josephine Loftus, Philippe Courtet, Caroline Dubertret, Emmanuel Haffen, Pierre Michel Llorca, Paul Roux, Mircea Polosan, Raymund Schwan, Ludovic Samalin, Emilie Olie, Bruno Etain, Fondamental Acad Centers Expertise Bipolar Disorder, Peggy Series, Raoul Belzeaux

Summary: This study investigates the relationship between different age cut-offs for early onset bipolar disorder (BD) and neurodevelopmental pathways. The results show that defining early onset as <=17 years best distinguishes neurodevelopmental patterns. These findings can improve patient stratification in future studies on BD pathophysiology and biomarkers.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychiatry

The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study

Lucia Sideli, Monica Aas, Diego Quattrone, Daniele La Barbera, Caterina La Cascia, Laura Ferraro, Luis Alameda, Eva Velthorst, Giulia Trotta, Giada Tripoli, Adriano Schimmenti, Andrea Fontana, Charlotte Gayer-Anderson, Simona Stilo, Fabio Seminerio, Crocettarachele Sartorio, Giovanna Marrazzo, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, Domenico Berardi, Giuseppe D'Andrea, Celso Arango, Manuel Arrojo, Miguel Bernardo, Julio Bobes, Julio Sanjuan, Jose Luis Santos, Paulo Rossi Menezes, Cristina Marta Del-Ben, Hannah E. Jongsma, Peter B. Jones, James B. Kirkbride, Pierre-Michel Llorca, Andrea Tortell, Baptiste Pignon, Lieuwe de Haan, Jean-Paul Selten, Jim Van Os, Bart P. Rutten, Richard Bentall, Marta Di Fort, Robin M. Murray, Craig Morgan, Helen L. Fisher

Summary: This study aimed to investigate whether the relationship between childhood maltreatment and cognition in patients with psychosis and community controls was influenced by genetic factors related to psychosis. The study included first-episode psychosis patients (N=755) and unaffected controls (N=1219) from the EU-GEI study, who were assessed for childhood maltreatment, intelligence quotient (IQ), family history of psychosis (FH), and polygenic risk score for schizophrenia (SZ-PRS). The results showed that controlling for FH and SZ-PRS did not weaken the association between childhood maltreatment and IQ in either cases or controls, suggesting that genetic liability factors do not explain the lower levels of cognition in adults who experienced childhood maltreatment.

SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2023)

Article Pharmacology & Pharmacy

A male mouse model of WIN 55,212-2 self-administration to study cannabinoid addiction

Maria del Mar Cajiao-Manrique, Rafael Maldonado, Elena Martin-Garcia

Summary: We have developed a mouse model of cannabinoid addiction using intravenous self-administration of WIN55,212-2. This model allows evaluation of addiction criteria including persistence of response, motivation for the drug, and compulsivity in the presence of punishment. It also measures parameters related to craving and predisposing factors. 35.6% of mice developed cannabinoid addiction criteria, allowing differentiation between resilient and vulnerable individuals. This model provides a reliable tool to study the neurobiological correlates of resilience and vulnerability to cannabinoid addiction.

FRONTIERS IN PHARMACOLOGY (2023)

Article Multidisciplinary Sciences

Open science and data sharing in cognitive neuroscience with MouseBytes and MouseBytes

Sara Memar, Eric Jiang, Vania F. Prado, Lisa M. Saksida, Timothy J. Bussey, Marco A. M. Prado

Summary: Open access to rodent cognitive data has been lagging behind other areas of neuroscience, but the use of touchscreen-automated cognitive testing in animal models provides standardized outputs that can be easily shared. These datasets can be combined with various neuro-technologies to analyze the relationship between neural activity and behavior. MouseBytes is a web-based repository that allows researchers to store, share, visualize, and analyze cognitive data, while MouseBytes+ integrates complementary neuro-technology data for multi-modal behavioral analysis.

SCIENTIFIC DATA (2023)

Article Psychiatry

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

Maria del Mar Cajiao-Manrique, Veronica Casado-Anguera, Alejandra Garcia-Blanco, Rafael Maldonado, Elena Martin-Garcia

Summary: This study investigates the development of cannabis addiction-like behavior in adult mice after adolescent exposure to THC. The results show that adolescent THC exposure does not affect the reinforcement of WIN 55,212-2 or the development of cannabis addiction-like behavior. However, THC pre-exposed mice display impulsive-like behavior in adulthood, especially in those that develop addiction-like criteria. Additionally, downregulated expression of drd2 and adora2a genes in NAc and HPC is observed in THC pre-exposed mice.

FRONTIERS IN PSYCHIATRY (2023)

Article Multidisciplinary Sciences

Persistent extrasynaptic hyperdopaminergia in the mouse hippocampus induces plasticity and recognition memory deficits reversed by the atypical antipsychotic sulpiride

Jill Rocchetti, Caroline Fasano, Gregory Dal-Bo, Elisa Guma, Salah El Mestikawy, Tak-Pan Wong, Gohar Fakhfouri, Bruno Giros

Summary: Evidence suggests that excessive dopamine affects cognitive function in schizophrenia and antipsychotic drugs fail to improve cognitive deficits. Blocking D2 dopamine receptors leads to reshaping of mesohippocampal fibers, synaptic transmission deficits, and impairments in learning and memory. It is currently unknown how excessive dopamine affects hippocampal-related cognitive functions and the impact of antipsychotic drugs on hippocampal functions in this state.

PLOS ONE (2023)

Article Multidisciplinary Sciences

Adipose tissue coregulates cognitive function

Nuria Oliveras-Canellas, Anna Castells-Nobau, Lisset de la Vega-Correa, Jessica Latorre-Luque, Anna Motger-Alberti, Maria Arnoriaga-Rodriguez, Josep Garre-Olmo, Cristina Zapata-Tona, Claudia Coll-Martinez, Lluis Ramio-Torrenta, Jose Maria Moreno-Navarrete, Josep Puig, Francesc Villarroya, Rafel Ramos, Veronica Casado-Anguera, Elena Martin-Garcia, Rafael Maldonado, Jordi Mayneris-Perxachs, Jose Manuel Fernandez-Real

Summary: Obesity is linked to cognitive decline. We found 188 genes associated with cognitive performance in different domains through RNA sequencing of adipose tissue in three cohorts. These genes are mainly involved in synaptic function, phosphatidylinositol metabolism, the complement cascade, anti-inflammatory signaling, and vitamin metabolism. Targeted misexpression of candidate gene ortholog in the Drosophila fat body significantly affected memory and learning, suggesting potential therapeutic targets in adipose tissue.

SCIENCE ADVANCES (2023)

Article Genetics & Heredity

Risperidone response in patients with schizophrenia drives DNA methylation changes in immune and neuronal systems

Ana Lokmer, Charanraj Goud Alladi, Rejane Troudet, Delphine Bacq-Daian, Anne Boland-Auge, Violaine Latapie, Jean-Francois Deleuze, Ravi Philip RajKumar, Deepak Gopal Shewade, Frank Belivier, Cynthia Marie-Claire, Stephane Jamain

Summary: The use of antipsychotic medication to treat schizophrenia is not always effective for all patients. Researchers have analyzed the blood DNA of patients and identified specific marks that could serve as biomarkers of antipsychotic response. Although specific predictive marks were not identified, valuable targets for future research have been identified.

EPIGENOMICS (2023)

No Data Available